Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03467503 · ClinicalTrials.gov registry record · NA

Healthy Diet for Healthy Moms and Babies

A NA study, sponsored by University of Nevada, Las Vegas.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT03467503: Completed NA study, sponsored by University of Nevada, Las Vegas.

NCT03467503 is a NA study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03467503, a NA study, has completed, sponsored by University of Nevada, Las Vegas.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

The purpose of this clinical study is to collect baseline information on dietary habits and metabolic risk factors, and to examine the effects of a dietary intervention focusing on fiber and antioxidant rich berries on the development of gestational diabetes, maternal glucose and lipid control and inflammation in obese pregnant women at risk of developing diabetes. With the ongoing epidemic of obesity, the prevalence of gestational diabetes is significantly increasing and the goal of this research is to identify optimal dietary strategies that can reverse this condition or control the rise in blood glucose among those with already developed diabetes.

Primary Outcome

Maternal weight gain in lbs

Interventions

  • DIETARY_SUPPLEMENT Blueberry + soluble fiber

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2018-05-01
Est. Completion 2020-08-31
Phase NA
University of Nevada, Las Vegas

52 total trials

What the finished NCT03467503 record still lists

NCT03467503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Blueberry + soluble fiber is the first listed.

NCT03467503 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03467503 about?

NCT03467503 is a clinical study titled "Healthy Diet for Healthy Moms and Babies". The purpose of this clinical study is to collect baseline information on dietary habits and metabolic risk factors, and to examine the effects of a dietary intervention focusing on fiber and antioxidant rich berries on the development of gestational diabetes, maternal glucose and lipid control and i...

What is the current status of trial NCT03467503?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2018-05-01. Estimated completion is 2020-08-31.

What interventions are being tested in trial NCT03467503?

The interventions under investigation include: Blueberry + soluble fiber (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03467503?

This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03467503's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03467503, the US trial registry maintained by the National Library of Medicine. NCT03467503 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.